Topics
Latest
AI
Amazon
Image Credits:Pepper Bio(opens in a new window)
Apps
Biotech & Health
clime
[Slide 3] Making it personal.Image Credits: Pepper Bio
Cloud Computing
Commerce
Crypto
[Slide 8] Here’s the problem.Image Credits: Pepper Bio
Enterprise
EVs
Fintech
[Slide 9] Tah-daaaa.Image Credits: Pepper Bio
Fundraising
widget
Gaming
[Slide 11] Well, the market is certainly big enough.Image Credits: Pepper Bio
Government & Policy
Hardware
[Slide 15] Revenue? Great. How much, though?!Image Credits: Pepper Bio
layoff
Media & Entertainment
[Slide 14] Um, what?Image Credits: Pepper Bio
Meta
Microsoft
Privacy
Robotics
Security
Social
outer space
startup
TikTok
transferral
speculation
More from TechCrunch
upshot
Startup Battlefield
StrictlyVC
Podcasts
TV
Partner Content
TechCrunch Brand Studio
Crunchboard
Contact Us
Happy New Year , and welcome to the 78th installment ofPitch Deck Teardown !
This workweek , we are consider a closer look atPepper Bio‘s seed pitch deck thatlanded the company $ 6.5 million . With the shibboleth “ The oddment of untreatable , ” the company is taking on a hell of a challenge : detect solution for all those illnesses Doctor ca n’t point well at the moment . Unlike CancerVax ( which Iripped aside in a previous teardownfor being completely unbelievable ) , Pepper Bio has a strong squad and a lot of hope .
We ’re looking for more unequaled pitch decks to pull down , so if you want to submit your own , here ’s how you may do that .
Before we plunk in , I have to admit that I do n’t deeply interpret this particular cut of biotechnology , and I had to do a fairish amount of Googling to fully understand the deck . As such , there ’s a chance I may get some things awry here . That also speaks to an important point , though : Your deck of cards needs to be well - targeted to its audience , and I ’m probably not the audience in this example . If I had been working with Pepper as one of my lurch coaching clients , I ’d have encouraged them to make the story come to life a lot more , with examples and anecdotes that are more relatable for a general universe . Having say that , the simple truth is that I’mnotthe target audience for this pack of cards : biotech investors are .
Give Anna ’s story from November a read for some context , and then we ’ll get to the pitch deck of cards itself :
Slides in this deck
Three things to love
The affair that confuses me the most about this pitch deck is thatsomeof the slides are incredibly accessible , while others are . . . Well , we ’ll get to that in just a moment .
A personal story
I love a good personal level . Tying yourself to the problem you are assay to solve avail a story come to life sentence ; it prevent a narrative from getting nonobjective or obtuse and enable you to speak from the heart . In this case , the CEO recount the story of their grandmother , and how the absence of treatments for Alzheimer ’s was a deplorable outcome .
Join us at TechCrunch Sessions: AI
Exhibit at TechCrunch Sessions: AI
plain , I have n’t heard the voice - over to this slide , but I think there are many ways it could be better ( a pic of the grandmother in question , perhaps ? ) . Still , this is a good first step .
ELI5
There ’s a subreddit called Explain Like I ’m 5 where masses attempt to excuse complex topics as if the reader were a five - twelvemonth - honest-to-goodness . Pepper Bio lose me a crew of times in this deck of cards , but then dispatch us with this unbelievable pair of slides :
This slide is a masterpiece . It explores the problem distance the party is attempt to address in incredibly simple Christian Bible .
And then derive the mic fall :
I love this duad of slides for their ease and power . They nail the tale and assist set the view beautifully for what is to come . In a man that ’s often laden with deeply technical language , Pepper Bio sets itself apart for a moment .
The mother of all market sizes
This sloping trough is , both in term of the visuals and cognitive content , a chef-d’oeuvre . It identifies three significant therapeutic areas with material food market opportunities : oncology , neurodegenerative disease , and incendiary disease . The financial figure provided are fairly impressive , betoken rich compound annual growth rates for each category .
The startup ’s designation of oncology as a market with a value of $ 201 billion in 2021 and a CAGR ( colonial yearly growth rate ) of 9.7 % is particularly notable . This paint a picture a deep understanding of a sector that is both in decisive need of innovation and restrain significant financial promise . The stark statistic that one out of six the great unwashed worldwide exit from cancer underscores the profound shock that advancements in this field could have .
It then goes on to reprise similar numbers for neurodegenerative disease and incitive disease , each with vast food market size and predict growth rates .
Overall , the sliding board does an excellent job of highlight Pepper Bio ’s possible compass and touch in areas that are not only financially vast , but also of critical importance to world health . A hell of a combo .
Now , of course , the companydoesneed to show that it is n’t spreading itself too thin and that it wee sense to go in all of those market segments . But that ’s a nitpick : Overall , this is one of the better market place size slides I ’ve ever seen .
In the rest of this teardown , we ’ll attend at three things Pepper Bio could have improved or done differently , along with its full pitch shot deck !
Three things that could be improved
There are a lot of things to love here , but we have some serious flops , too :
That’s not how traction works
On three whole swoop ( slither 15 through 17 ) , the company says it is generate revenue but then does n’t excuse how much . Each of these slides include cooking stove and suggestions , which frustrates me and makes me mistrustful . If you say you ’re generating income , then it ’s probably easy to show how much money has flowed into the banking concern account . It ’s rather strange to leave alone that crucial moment out .
It would have been far better to show this as a chart or graph to give some idea how much taxation has been booked .
English, please
I ’ve read this slide a half dozen time and I can not wrap my head around what it is say :
I do n’t know what “ HCC ” is — it is n’t defined in the pack of cards . It could be hepatocellular carcinoma ( HCC ) , which , per the Mayo Clinic , is the most common type of chief liver Crab . But it could also be something else . There ’s pot of blank space on this lantern slide to spell it out .
Also , I am curious about the sample size of it here . How many animals were tested ? What case of animals ?
I ’m not certain what “ fomite ascendency ” means , either . What is a “ vehicle ” in this linguistic context ? Is that a expert full term ? Could it just say “ control grouping ” ?
Does “ standard of aid ” refer to the regular treatments currently used for this eccentric of tumor ? If so , what is that treatment ?
What does “ Pepper Bio target ” mean in this context ? The cells the fellowship is aim ?
I ’m having to do a pile of guesswork here , and I ’m leave alone confused . The company talks about animals and “ the clinic , ” but I ’m not sure if this means that it contrive to continue to treat animals for this illness , or whether that means it is planning to start treating humans ? Would n’t there be some sort of FDA approval operation ?
All in all , this glide is a Brobdingnagian piece of confusion sandwiched between needlessly proficient spoken language , in my vox populi .
No ask or use of funds
The fellowship raised $ 6.5 million , but the slides never explicate what the company is planning to fulfil with the money . The pack of cards is pretty mitt - wavey about grand vision for the future , and I have no doubt that Pepper Bio , if it bear on its promise , can continue to conjure money and be successful .
But as an investor , you ’re test to gauge what the next step of the journeying is last to be , and whether that will generate enough adhesive friction to get the company to a good plaza . That ’s completely unclear here , which makes it very hard to square off whether $ 6.5 million is a reasonable amount to raise and whether the troupe is on the good track .
The full pitch deck
If you want your own pitch deck teardown have on TC+,here ’s more information . Also , check outall our Pitch Deck Teardowns and other pitching advice , all accumulate in one ready to hand place for you !
